Vanguard Group Inc

SEC CIK: 0000102909
Latest filing: Jan 29, 2026

SEC filings (opens in a new tab)

ZVSA holding history

ZyVersa Therapeutics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ZVSA overview All 13F holders of ZVSA Full Q4 2025 holdings

Shares (Q4 2023): 0; Sold out in Q4 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2023

Holdings of ZVSA by Vanguard Group Inc, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2023	0	$0	0.0%	−17,194−100.0%	Sold out	Holders
Q3 2023	17,194	$2.23K	<0.1%	00.0%	Unchanged	Holders
Q2 2023	17,194	$4.22K	<0.1%	+300+1.8%	Added	Holders
Q1 2023	16,894	$32.6K	<0.1%	+16,894	New	Holders